As aberrant mRNA splicing frequently occurs in tumors26, we tested this hypothesis by comparing the percentage of full-length ATG5 (ATG5v1) expression from total ATG5 expression in normal and tumor samples within The Cancer Genome Atlas (TCGA) datasets possessing at least 15 normal samples. Here, ATG5 is linked to neoplasm.